MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 23 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,108,000 | +4.9% | 829,978 | -16.2% | 0.00% | – |
| Q1 2020 | $2,010,000 | -0.1% | 990,501 | +6.3% | 0.00% | – |
| Q4 2019 | $2,013,000 | +149.4% | 932,142 | +78.0% | 0.00% | – |
| Q3 2019 | $807,000 | -95.9% | 523,623 | -88.9% | 0.00% | -100.0% |
| Q2 2019 | $19,617,000 | +453.4% | 4,727,167 | +457.4% | 0.00% | +50.0% |
| Q1 2019 | $3,545,000 | +228.8% | 848,120 | +125.7% | 0.00% | – |
| Q4 2018 | $1,078,000 | -85.8% | 375,700 | -50.5% | 0.00% | -100.0% |
| Q3 2018 | $7,583,000 | +156.9% | 758,300 | +81.6% | 0.00% | +200.0% |
| Q2 2018 | $2,952,000 | -15.4% | 417,500 | -54.3% | 0.00% | 0.0% |
| Q1 2018 | $3,488,000 | +104.0% | 912,891 | +335.4% | 0.00% | – |
| Q4 2017 | $1,710,000 | +240.0% | 209,662 | +144.9% | 0.00% | – |
| Q3 2017 | $503,000 | +379.0% | 85,618 | +48.2% | 0.00% | – |
| Q3 2016 | $105,000 | – | 57,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |